Research Areas

• Cancer
• Methodology
• Other conditions

Related Studies

• FOCUS-3
• FOCUS4
• PROMIS
• STAMPEDE
• STAMPEDE2

Related News

'25 at 25': Extending the use of drugs - repurposing and beyond
16 Dec 2024

'25 at 25': Improving prostate cancer diagnosis
13 Nov 2024

No clear evidence that adding diabetes drug to standard prostate cancer treatment reduces risk of death, but side effects of hormone therapy lessened
16 Sep 2024